Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00264823 · ClinicalTrials.gov registry record · Phase 2
Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)
A Phase 2 study of HIV and Mental Illness, sponsored by National Institute of Nursing Research (NINR).
- Completed
- Registry status
- Phase 2
- Development phase
- 273
- Enrollment target
- 1
- Study location
NCT00264823: Completed Phase 2 study of HIV and Mental Illness, sponsored by National Institute of Nursing Research (NINR).
NCT00264823 is a Phase 2 study of HIV and Mental Illness that has completed, run by National Institute of Nursing Research (NINR). The registered enrollment target is 273 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00264823, a Phase 2 study of HIV and Mental Illness, has completed, sponsored by National Institute of Nursing Research (NINR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate how nurses can best help people with serious mental illnesses (SMI) follow their HIV treatment plans.
Conditions Studied
Interventions
- BEHAVIORAL Use of Memory Aids to take medications
Study Locations (1)
Pennsylvania
- Center for Mental Health Services and Policy Research - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
What the finished NCT00264823 record still lists
NCT00264823 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (38% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Use of Memory Aids to take medications is the first listed.
NCT00264823 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00264823 about?
NCT00264823 is a clinical study titled "Nursing Intervention for HIV Regime Adherence Among People With Serious Mental Illness (SMI)". The purpose of this research study is to investigate how nurses can best help people with serious mental illnesses (SMI) follow their HIV treatment plans.
What is the current status of trial NCT00264823?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 273 participants. The study started on 2003-06. Estimated completion is 2008-05.
What conditions does trial NCT00264823 study?
This clinical trial studies the following conditions: HIV, Mental Illness.
What interventions are being tested in trial NCT00264823?
The interventions under investigation include: Use of Memory Aids to take medications (BEHAVIORAL).
Who is sponsoring clinical trial NCT00264823?
This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00264823 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00264823's enrollment target sits among peer trials
273 77th of 303 higher than 227 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Improving Physical Ability and Cellular Senescence Elimination in HIV
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
RECRUITING · Phase 2
-
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
RECRUITING · Phase 2
-
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia